AgriTech

A multidisciplinary sector addressing the challenges of improving global agricultural productivity.

Agriculture is at the heart of human civilization, but traditional methods alone can’t meet the demands of our growing population and changing climate. Enter Agritech – the fusion of agriculture and technology. Agritech is transforming farming practices, enhancing productivity, and ensuring sustainability for future generations. Improvements in efficiency and sustainability in agriculture continue to drive ingenious solutions that harness various cutting-edge technologies, such as genomics and gene editing, robotics, microbiome, big data, algorithms and AI.

As such, inventions in this sector increasingly involve crossover technologies. Our Agritech Team includes highly experienced attorneys across life sciences, chemistry, and engineering, who are familiar with pooling expertise and working in multidisciplinary teams to service your IP needs. Our Agritech Team works closely with our unique specialists in microbiome and bioinformatics, and can further assist with seeking protection for plant variety rights alongside patents.

HGF’s attorneys are already working at the forefront of agricultural innovation. We deal with inventions in accelerated plant breeding procedures, algal culturing, genetically engineered or modified crops, actives and formulations for plant protection products such as herbicides and pesticides, soil monitoring and preparations, growing and farming apparatus, surveillance and diagnostics, precision and digital agriculture, genetically engineered or modified animals, improved husbandry methods, microbiome and carbon neutral systems.

We believe in building lasting partnerships with our clients. Our team of experts is always available to provide integrated IP support and guidance, helping you make the most of your agritech inventions.

For more information on how our Agritech team can help you with your IP, please contact us to speak with one of our attorneys.

Latest updates

Building to Survive: Designing Life Sciences Patent Portfolios to Withstand a Challenge

The strongest life sciences IP strategies are not designed simply just to obtain a series of patents. They are designed around the challenges those patents may have to withstand five, …

Read article

HGF Presents - Protecting Plant Innovation

In this video, we explore the statutory and regulatory barriers to the patentability of plant-related inventions in the US and Europe, before considering the landscapes further afield. Given the divergent …

Read article
Event - 12th November 2026

HGF Partners with PPTI for 'Designing Foods for Healthy Aging' Webinar

As healthy aging, metabolic health and weight management rise up the consumer agenda, food and nutrition businesses are increasingly looking beyond traditional product development and towards solutions that deliver measurable …

Event details

Basel Seminar: Seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU

Venue – Der Teufelhof Basel, Switzerland We are pleased to invite you to our seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU. …

Read article

Where Does the Real IP Value Lie in AI-Enabled Life Sciences?

After attending the BioTechX conference in Basel last week, talking to people working across pharma, biotech, AI, software, laboratory automation and data management, my main takeaway was clear: the conversation …

Read article

When AI Designs the Ingredient: Who Controls the Data, the Model and the Discovery?

AI-enabled discovery has drawn significant attention in pharmaceutical R&D, but its impact is extending into other industries, across ingredients, food, flavour, fragrance and industrial biotechnology. As AI models advance, the …

Read article

Protecting the AI Drug Discovery Ecosystem: Building an IP Stack Around Targets, Molecules and Medicines

Despite the considerable costs and effort in target identification, candidate generation, selection and advancement to clinical trials, 90% of candidates that enter clinical trials during drug discovery fail (Sun D, …

Read article

Agritech Thymes: UK-EU SPS agreement – what does it mean for plant breeders?

Since Brexit, the UK agrifood sector has faced difficulties, largely due to the requirement for additional certifications and controls, such as phytosanitary certificates and border checks. This has had a …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our agritech specialists.